Word this month that Regeneron Pharmaceuticals Inc. and partner Sanofi-Aventis Group decided to quit their Phase III trial with aflibercept (VEGF Trap) for first-line metastatic pancreatic cancer put new focus on the grim, quick-spreading tumor type, much in the news as a result of actor Patrick Swayze's death last week. Read More
